CI · Cigna Corporation
$270.022026-05-17Sector: Healthcare; Industry: Medical - Healthcare Plans; Sub-Industry: Health Care Services
Intrinsic Value Range Comparison · Mulya.ai
Bull
$2495
+823.8% vs market
Base · active
$323
+19.5% vs market
Bear
$774
+186.7% vs market
Mulya.ai vs Analyst IV Comparison?
Mulya.ai IV range ($774 · $2495) Analysts Range ($300 · $375) Fundamentals · historical + forward · baseitalics = DCF projection
| Period | Revenue | Rev Gr ? | Ops M% ? | Tax Rate ? | NOPAT ? | Reinvest ? | FCFF ? | WACC% ? | PV FCFF ? | ROIC ? | Inv. Cap ? | EPS ? | P/E |
|---|
| 2021.Q4 | $174.1B | — | 4.6% | 20.2% | $6.3B | −$997MM | $5.3B | 2.9% | — | 8.5% | $74.9B | $20.19 | — |
| 2022.Q4 | $180.5B | 3.7% | 4.7% | 19.2% | $6.8B | $7.1B | $13.9B | 4.9% | — | 9.5% | $69.2B | $25.21 | — |
| 2023.Q4 | $195.3B | 8.2% | 4.4% | 2.6% | $8.3B | $4.5B | $12.8B | 5.1% | — | 12.1% | $68.3B | $19.42 | — |
| 2024.Q4 | $247.1B | 26.6% | 3.8% | 28.3% | $6.8B | $3.0B | $9.7B | 5.4% | — | 10.1% | $64.7B | $12.91 | — |
| 2025.Q4 | $275.0B | 11.3% | 3.3% | 17.7% | $7.5B | $6.0B | $13.5B | 5.2% | — | 11.5% | $65.5B | $22.40 | 7.9 |
| italics below = DCF projection · 10yr Rev CAGR: 6.9% |
| 2026.Q4 | $284.9B | +3.6% | 3.4% | 17.9% | $7.8B | −$4.7B | $3.2B | 6.0% | $3.0B | 11.6% | $70.2B | $29.47 | 9.2 |
| 2027.Q4 | $301.8B | +5.9% | 3.5% | 18.2% | $8.7B | −$6.0B | $2.7B | 6.3% | $2.4B | 11.9% | $76.2B | $32.67 | 8.3 |
| 2028.Q4 | $319.8B | +6.0% | 3.6% | 18.4% | $9.3B | −$5.1B | $4.2B | 6.5% | $3.5B | 11.8% | $81.3B | $35.10 | 7.7 |
| 2029.Q4 | $352.7B | +10.3% | 3.7% | 18.6% | $10.5B | $0MM | $10.5B | 6.8% | $8.2B | 12.9% | $81.3B | $39.58 | 6.8 |
| 2030.Q4 | $389.8B | +10.5% | 3.7% | 18.9% | $11.6B | $0MM | $11.6B | 7.0% | $8.5B | 14.3% | $81.3B | $43.62 | 6.2 |
|
| Term. Yr+ | $560.1B | 4.1% | 9.4% | 20.0% | $41.9B | −$20.0B | $21.9B | 8.6% | $243.9B | 8.6% | — | — | — |
Active scenario IV: $323 (+19.5% vs market)